1. Introduction {#sec1-molecules-21-01229}
===============

Flavonoids are present in plants mainly as glycosides; glucuronides, in which uronic acids occur as sugar units, are less frequent \[[@B1-molecules-21-01229]\]. The role of glucuronides in plants has not been yet clarified. It is speculated that they can provide protection against herbivores \[[@B2-molecules-21-01229]\]. Flavonoid glucuronidation can also be catalyzed by enzymatic reactions in human and animal metabolic pathways \[[@B3-molecules-21-01229]\].

The main flavonoid glucuronides identified thus far in plants include glucuronoflavones, especially apigenin and luteolin, as well as tricin, chrysoeriol, scutellarein and the glucuronoflavonols quercetin, kaempferol, isorhamnetin and myricetin \[[@B4-molecules-21-01229]\]. These constituents have been reported in Asteraceae (*Cirsium rivulare*, *Erigeron multiradiatus*, *Tanacetum parthenium*) \[[@B5-molecules-21-01229],[@B6-molecules-21-01229],[@B7-molecules-21-01229]\], Polygonaceae (*Polygonum amphibium*, *P. aviculare*) \[[@B1-molecules-21-01229],[@B8-molecules-21-01229]\], Lamiaceae (*Scutellaria indica*, *S. baicalensis*, *Salvia officinalis*, *S. palestina* \[[@B9-molecules-21-01229],[@B10-molecules-21-01229],[@B11-molecules-21-01229],[@B12-molecules-21-01229]\], Scrophulariaceae (*Picria fel-terrae*) \[[@B13-molecules-21-01229]\], Pedaliaceae (*Uncarina* sp.) \[[@B14-molecules-21-01229]\] and Chenopodiaceae (*Spinacia oleracea*) \[[@B15-molecules-21-01229]\]. Diglucuronoflavones identified in a few species from Fabaceae (*Medicago truncatula*, *M. radiata*, *M. sativa*) \[[@B16-molecules-21-01229],[@B17-molecules-21-01229],[@B18-molecules-21-01229],[@B19-molecules-21-01229]\], Lamiaceae (*Perilla ocimoides*) \[[@B20-molecules-21-01229]\], Poaceae (*Secale cereale*) \[[@B21-molecules-21-01229]\] and Hydrocharitaceae (*Elodea canadensis*) \[[@B22-molecules-21-01229]\] are particularly rare. In *Medicago* sp., isolated diglucuronoflavones were additionally acylated with the hydroxycinnamic acids caffeic, ferulic, sinapic and *p*-coumaric acids \[[@B17-molecules-21-01229],[@B18-molecules-21-01229],[@B19-molecules-21-01229]\].

Some glucoronidic derivatives of flavonoids have been shown to exert antioxidant and anti-inflammatory activities \[[@B8-molecules-21-01229],[@B23-molecules-21-01229]\]. In in vitro studies, quercetin 3-*O*-glucuronide prevented vascular smooth muscle cell hypertrophy by angiotensin II. Moreover, flavonol glucuronides from *Polygonum amphibium* L. induced apoptosis in HL-60 and Jurkat cells \[[@B1-molecules-21-01229]\]. A study conducted in rabbits demonstrated that a flavonoid glucuronide fraction isolated from *Tulipa gesneriana* exerted microvascular protective effects against skin vascular permeability induced by chloroform or histamine \[[@B24-molecules-21-01229]\].

*Axyris amaranthoides* L. (*Chenopodiaceae*) is a herbaceous annual plant (20--80 cm in height), commonly known as Russian Pigweed. This plant originated in Asia but is naturally widespread throughout the USA. *A. amaranthoides* herb is used in Chinese folk medicine as a gastrointestinal spasmolytic and to regenerate the liver, as well as alleviating rheumatic pain and swelling \[[@B25-molecules-21-01229],[@B26-molecules-21-01229]\].

Utilization of liquid chromatography and mass spectrometry in analysis of phenolic compounds, especially flavonoids, is extensively studied in the literature and the use of different mass spectrometric analyzers and ionization techniques have grown to be the most common method in this type of studies \[[@B27-molecules-21-01229],[@B28-molecules-21-01229]\]. High resolution tandem mass spectrometry (MS/MS) systems are capable to deliver precise information on molecular weight of compounds, and collision induced dissociation (CID) fragmentation used together with soft ionization techniques provides additional structural information \[[@B29-molecules-21-01229]\]. Moreover, analysis of samples in both positive and negative ionization modes may support the study due to different fragmentation patterns of protonated and deprotonated molecules \[[@B30-molecules-21-01229]\]. Nevertheless, all this information is not sufficient for complete structural elucidation of studied compounds due to almost identical fragmentation pathways of positional isomers. This situation is in accordance with flavonoid derivative fragmentation, where sugar moieties can be substituted at different positions of aglycones; moreover, these sugar moieties are often also acylated with organic acids at different hydroxyl groups \[[@B27-molecules-21-01229]\]. There are some proposals in literature trying to find a method to distinguish differentially substituted isomeric flavonoid molecules. One of them is measuring relative abundances of specific fragmentation ions \[[@B31-molecules-21-01229]\], and the other is electrospray ionization (ESI) analysis of metal complexes \[[@B32-molecules-21-01229]\]. Such approaches are interesting but do not allow unambiguous identification and depend strongly on analysis parameters and interpretation skills. The only confident way for complex structural analysis is still the use of different complementary spectroscopic methods for elucidation of molecule structure. In most cases, information derived from NMR and MS analysis leads to unambiguous structure elucidation \[[@B17-molecules-21-01229],[@B18-molecules-21-01229]\]. Such approaches are possible only when compound of interest is present in relatively high concentrations and can be purified from the complex mixtures. Another way to confirm proper compound identification is the use of purified or commercially available standards. This way, it is possible to compare retention times of standards with potentially identified compound as well as comparison of their MS and multiple MS/MS (MSn) spectra. This approach is also commonly used in combination with ultraviolet diode array detectors (UV-DAD) \[[@B33-molecules-21-01229]\]. High resolution MS was used to identify saponins and flavonoids in *Camellia oleifera* \[[@B34-molecules-21-01229]\], using a ultra high performance liquid chromatography coupled with electrospray ionization hybrid linear trap quadrupole orbitrap mass spectrometry (UHPLC-LTQ-orbitrap-MSn) system, it was possible to tentatively characterize seven flavonol glycosides, and MS^3^ spectra were used for unambiguous aglycone characterization. Another interesting work showing usefulness of the high performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MSn) approach for comprehensive plant metabolites characterization was published by Wang and co-workers \[[@B35-molecules-21-01229]\], where authors propose general strategies for analysis of complex samples. Application of such a strategy allowed temporary identification of 48 flavonoid derivatives among 144 compounds in total, while NMR analysis was further used for structures confirmation of some novel compounds.

Based on a literature search, *A. amaranthoides* has been the subject of just several phytochemical studies. Extracts of *A. amaranthoides* roots and seeds were found to contain large amounts of phytoecdysteroids, and 1α,20*R*-dihydroxyecdysone, 20*E*-hydroxyecdysone (polypodine A) and 5,20*E*-dihydroxyecdysone (polypodine B) have been isolated \[[@B36-molecules-21-01229],[@B37-molecules-21-01229]\]. There is no further information in the available literature on flavonoid content of *A. amaranthoides* that we could confront with our results. This facts are making analysis on MS systems more difficult due to lack of information on general glycosylation pattern of aglycones provided by enzymatic systems responsible for acylation and glucosidation of flavonoids specifically in *A. amaranthoides*. Therefore, all proposed structures in this paper should be treated as tentative and are based on the most common substitution patterns found in available literature.

In this study, we demonstrate that *A. amaranthoides* herb is a rich source of flavonoid compounds, mainly tricin acylated glucuronides, which are quite rare in plants. To the best of our knowledge, some of the structures proposed here have been shown for the first time in plants.

2. Results and Discussion {#sec2-molecules-21-01229}
=========================

2.1. Flavonoid Glycosides of Axyris amaranthoides {#sec2dot1-molecules-21-01229}
-------------------------------------------------

Due to the presence in examined fractions of a large number of flavonoids of similar structures and polarities, the chemical constituents in the mixture were identified using HPLC combined with high-resolution tandem quadrupole-time of flight (QToF) mass spectrometry. A detailed analysis of the MS and MS^2^ spectra led to the successful characterization of 35 flavonoid conjugates, including previously identified compounds \[[@B19-molecules-21-01229]\] and previously unknown flavonoid derivatives.

All of the tentatively identified compounds are presented in [Table 1](#molecules-21-01229-t001){ref-type="table"}. Most of them were tricin derivatives (18 compounds). Others compounds included derivatives of chrysoeriol (seven compounds), isorhamnetin (five compounds), apigenin (two compounds), luteolin (one compound) and syringetin (one compound). Assigning the correct structures for aglycones was possible due to pseudo MS^3^ analysis and comparison of obtained fragmentation spectra with spectra of standards and spectra found in literature or deposited in common spectral libraries. This work was done as described in our earlier papers \[[@B19-molecules-21-01229],[@B38-molecules-21-01229]\]. Structures of identified aglycones are presented in [Figure 1](#molecules-21-01229-f001){ref-type="fig"}, and fragmentation spectra and proposed structures of the conjugates are shown in [supplementary data (Figures S1--S35)](#app1-molecules-21-01229){ref-type="app"}. The conjugates included both acylated and non-acylated flavonoid glycosides with attached glucose, xylose and/or glucuronic acid moieties. Most of the recognized metabolites were acylated with various phenolic acids, 13 metabolites were feruloylated, nine metabolites were acylated with *p*-coumaric acid, and one metabolite was acylated with sinapic acid. Additionally, we propose that two of the metabolites were acylated with dehydrodiferulic acid, and one was acylated with benzoic acid.

Because we exclusively used MS techniques to identify the mixture components, we were unable to assign the positions of particular moieties in aglycone molecules, and we were also unable to distinguish the exact sugar substituents. Based only on our experience and the available literature, we propose tentative structures of identified compounds. We are aware that analysis of standards should be done to perform correct confirmation of our statements; nevertheless, we dealt with complex mixtures of compounds often found in very low concentrations, and additional separation of specific compounds or even chemical synthesis would be impossible or very complicated and time-consuming. Many studies have described the typical substitution patterns of flavonoids. NMR studies have identified the phenylpropenoic acidic moieties (*p*-coumaric, ferulic and sinapic acids) of these conjugates, and the positions of the ester bonds and the glycosidic bonds between the aglycone and the sugar moiety(ies) have been established \[[@B16-molecules-21-01229]\]. In addition, reports of similar structures have been confirmed in various species \[[@B17-molecules-21-01229],[@B18-molecules-21-01229]\]. It should be noted here that, thanks to use of the high resolution mass spectrometry (HRMS) system, we were able to distinguish isobaric fragment losses of ferulate moiety from glucuronate moiety (loss of 176.046 Da to 176.031 Da), and coumarate from rhamnose moiety (loss of 146.036 Da to 146.057 Da). Additionally, these isobaric substituents can be differentiated based on comparison of positive and negative ion fragmentation spectra, since ferulate gives a characteristic neutral loss of 194 Da and coumarate gives a loss of 164 Da. Based on these findings, we propose certain structures for the flavone derivatives found in *Axyris amaranthoides* with the reservation that these structures were not determined directly using analytical methods that permit unambiguous determination.

In this study, all samples were analyzed in both positive and negative ion modes, spectra were acquired using a high-resolution q-ToF mass spectrometer that enabled precise measurements of *m*/*z* values for all \[M + H\]^+^ and \[M − H\]^−^ ions in both MS and MS^2^ modes. Because we have previously discussed the necessity for high-resolution MS systems \[[@B19-molecules-21-01229]\], here we will only emphasize the inability of low-resolution MS analyzers such as quadrupole or ion trap instruments to determine isobaric compounds or isobaric fragment ions. Furthermore, knowing the exact mass of protonated or deprotonated ions and having precisely calibrated the system prior to analysis enhances the ability of these methods to correctly determine structures. Finally, the use of a UPLC system greatly affected the acquisition of the data; chromatographic resolution was an important factor in the analysis due to the close structural similarities of some of the flavone glucuronides. It is notable that the resolving power of UPLC systems enabled the studied compounds to be separated within 8 min during a 12-min chromatographic run. Hyphenation of this system with a fast high-resolution mass spectrometer allowed the acquisition of MS^2^ spectra for consecutive compounds. [Figure 2](#molecules-21-01229-f002){ref-type="fig"} shows the extracted ion chromatogram (EIC) for the product ion at *m*/*z* 815; seven peaks were observed, three of which were successfully characterized based on their exact mass and fragmentation spectra ([Figure 3](#molecules-21-01229-f003){ref-type="fig"}).

Each of the compounds has a different aglycone, i.e., chrysoeriol (**3**), luteolin (**4**) and isorhamnetin (**27**). Furthermore, compounds **4** and **27** are isomers. In addition to containing different aglycones, these two conjugates are acylated differently. Compound **4** is conjugated with ferulic acid, and compound **27** is conjugated with coumaric acid; thus, these two compounds have the same molecular formula. These acylating moieties were differentiated using positive and negative ion mode fragmentation spectra. The mass of compound **3** differs from those of compounds **4** and **27** by approximately 40 mDa, which is too large of a difference to be attributed to improper calibration; we propose it has a different molecular formula so that these results suggest that compound **3** is isobaric with compounds **4** and **27** (see [Table 1](#molecules-21-01229-t001){ref-type="table"}). Again, analysis of positive and negative spectra leads to unambiguous identification of the substituents in compound **3**. Other isomeric compounds were differentiated in our study by analyzing fragmentation spectra, including the following compound pairs: **29** and **30**, **18** and **20**, **10** and **23**, **11** and **25**, **13** and **15**, and **14** and **21**. Other pairs of isobaric compounds that were effectively recognized in extracts of *Axyris* *amaranthoides* are **1** and **22**, and **6** and **12**.

2.2. Fragmentation Pathways of Flavone Glycoconjugates {#sec2dot2-molecules-21-01229}
------------------------------------------------------

Only eight out of the 35 compounds detected in *Axyris amaranthoides* were non-acylated flavone mono- and diglycosides. These compounds contained linear saccharides, which were attached most probably at position 7 of chrysoeriol and tricin. Based on previously reported work \[[@B39-molecules-21-01229],[@B40-molecules-21-01229]\], the most probable site of glycosylation is position 3 of isorhamnetin, but based only on MS/MS spectra, we can not exclude the possibility that the saccharides are attached at position 7 as well. Compounds **8**, **16** and **28** were mono-glucuronates of isorhamnetin, tricin and chrysoeriol, respectively. The glycosidic moiety of compounds **1**, **2** and **5** comprised two combined glucuronic acid molecules, and compound **22** was glucuronosylo-glucoside but with two sugar moieties substituted at different positions. Compound **26** contained one methyl ester of glucuronic acid.

CID fragmentation spectra of these compounds, which were acquired in positive ion mode, included only product ions that were created after successive cleavages of glycosidic bonds between sugars and between the sugar moiety and the aglycone (see [Supplementary Materials](#app1-molecules-21-01229){ref-type="app"}). A positive charge was retained on the aglycone, and an entire series of Y~n~^+^ product ions were observed \[[@B41-molecules-21-01229],[@B42-molecules-21-01229]\]. This fragmentation pattern is equivalent to that observed earlier by us \[[@B19-molecules-21-01229]\] and to patterns observed by others for all flavonoid glycosides \[[@B42-molecules-21-01229]\].

The fragmentation pathway observed in the negative ion mode (deprotonation) was different from the fragmentation pathway observed in the positive ion mode. As in our previous work \[[@B19-molecules-21-01229],[@B27-molecules-21-01229]\], we observed a predominant loss of aglycones in the case of diglycosides, and the charge was retained on the sugar moiety, representing the most abundant peak in the spectrum. For diglucuronides, we observed an ion at *m*/*z* 351, which is typical of these compounds, as described in our previous study \[[@B19-molecules-21-01229]\]. Interestingly, for monoglucosides, the fragmentation pathway observed in the negative ion mode is similar to that observed with positive spectra; namely, we observed a loss of sugar and charge retention on the aglycone, which suggests that only di- and triglucuronate moieties can efficiently stabilize the negative charge. This finding is consistent with other reports \[[@B43-molecules-21-01229]\]. In the positive ion mode, a loss of hexose was observed from compound **22**, followed by the loss of glucuronic acid; however, in the negative ion mode, the opposite was true, i.e., glucuronic acid was lost before hexose. This clearly indicates that the two substituents are directly attached to the aglycone in different positions; therefore, it is not possible that these two sugar moieties are linked to each other. In this case, analysis of mass spectra does not give the information on exact position of glucuronic acid with respect to glucose moiety.

The glycosylated flavone tricin 7-*O*-\[glucuronopyranosyl-(1-2)-*O*-methylglucuronopyranoside\] (compound **26**) was also recognized. When compared to compound **5**, which is a non-methylated tricin diglucuronide, we observed a completely different fragmentation scheme. In the methylated diglucuronide, charge is retained on an aglycone fragment in the negative mode; therefore, MS/MS spectra recorded for **26** using the positive and negative ion modes appear very similar. This demonstrates that although two carboxyl groups in the diglucuronate moiety strongly stabilize the product ion \[[@B19-molecules-21-01229]\], blocking one of these carboxyl groups dramatically alters the stability of this negative ion, resulting in charge retention on the aglycone. Few studies have analyzed flavone diglucuronides using negative-ion MS/MS, although many quercetin and methylquercetin diglucuronides have been isolated from animal tissues or body fluids \[[@B44-molecules-21-01229],[@B45-molecules-21-01229]\]. In these reports, no product ion at *m*/*z* 351 was reported, suggesting either that quercetin glucuronides act differently or that both sugars were attached to different hydroxyl groups on the aglycone. However, the cited authors did not address this issue.

2.3. Fragmentation Pathways of Acylated Flavone Glycoconjugates {#sec2dot3-molecules-21-01229}
---------------------------------------------------------------

Among the compounds found in this work, 27 were acylated with various phenolic acids, mainly ferulic acid (16 compounds) and *p*-coumaric acid (nine compounds), and with sinapic, benzoic and hydroxyferulic acids (one compound each). In addition, we found two tricin conjugates, which we propose are acylated with dehydrodiferulic acids. All of the characterized flavonoid conjugates contained at least two sugar moieties, and some contained three. We detected no acylated monoglycosylated flavones, consistent with our previous report \[[@B19-molecules-21-01229]\] and those of others \[[@B16-molecules-21-01229],[@B17-molecules-21-01229],[@B18-molecules-21-01229]\].

Analysis of the fragmentation pathways of acylated flavones showed that they behave similarly to non-acylated compounds, especially in the positive ion mode, for which we observed a sequential loss of consecutive substituents that left the aglycone ion as a final fragment. Apparently, terminal phenolic acid groups always leave the pseudomolecular ion together with the sugar units to which they are connected; consequently, we observed characteristic losses of 352 Da for ferulate and 322 Da for coumarate. The same effect was observed with hydroxyferulate (368 Da) and benzoate (280 Da). However, because only one of each type of these compounds (**23** and **32**) was observed in our experiment, we cannot be certain that this result is common in all such cases.

When phenylpropenoic acid units were attached to non-terminal sugar moieties, we observed different fragmentation behavior: for compounds **7**, **9**, **11**, **13**, **14** and **15**, in which the middle glucuronates were acylated, we observed the loss of a single sugar unit (in all cases, this sugar was a hexose, presumably glucose (162 Da)). Subsequently, an acylated glucuronide fragment was removed from the resulting protonated residue, and the final fragmentation step was cleavage of the *O*-glycosidic bond between glucuronic acid and the aglycone. For compound **21**, we assigned the acylation position to the glucuronate unit that was directly attached to tricin. The initial fragmentation step was the elimination of a glucuronate-glucose moiety (352 Da); this step was followed by the loss of a ferulate unit. Surprisingly, in the final fragmentation step, a charge was retained on the glucuronic acid residue, which is not typical of positive ion mode fragmentation.

The fragmentation spectra of acylated glycoconjugates acquired in the negative ion mode were interesting; we observed common fragment ions having characteristic masses of *m*/*z* 497, *m*/*z* 527 and *m*/*z* 513. These masses correspond to acylated sugar moieties comprising two molecules of glucuronic acid or glucuronic acid conjugated to a glucose unit. We have previously described fragmentation pathways leading to these fragments \[[@B19-molecules-21-01229]\]. Here, we report a further characteristic ion at *m*/*z* 495, which corresponds to a linear fragment comprising two units of glucuronic acid and one unit of glucose ([Figure 4](#molecules-21-01229-f004){ref-type="fig"}a). This fragment was detected in the spectra obtained for compounds **9**, **13**, **14**, **15** and **21** and appears to be present only when sugar rings are connected by glycosidic bonds in positions 1 → 2. We did not observe this ion in compounds **7** and **11**, which also contain linear triglucosides, but instead observed a glycosidic bond in positions 1 → 3 between the two units (see the [Supplementary Materials](#app1-molecules-21-01229){ref-type="app"}). Another observed ion that was not previously reported is a fragment of *m*/*z* 511 that was observed in the negative ion spectrum of compound **33**; we assigned this result to a fragment that originated from *p*-coumaric acid and two units of glucuronic acid, in which one of these units contained a methylated carboxyl group ([Figure 4](#molecules-21-01229-f004){ref-type="fig"}b).

As was demonstrated above by the results obtained for compound **22**, the analysis of spectra that were acquired in both positive and negative ion modes resulted in the tentative identification of structures with sugar moieties substituted at two positions. This was also observed with the acylated compounds **24** and **25**. In the positive ion spectrum, we observed two possible losses occurring from the pseudomolecular ion: the loss of a fragment (132 Da) corresponding to a pentose molecule (presumably xylose) and a second possible cleavage that can be attributed to the loss of coumaroyl glucuronide (322 Da). Further fragmentation steps form a deprotonated chrysoeriol molecule. In addition, in the negative ion spectrum, we observed the loss of a neutral pentose fragment, followed by cleavage of an aglycone, to a characteristic ion at *m*/*z* 497, representing a deprotonated coumaroyl diglucuronide \[[@B19-molecules-21-01229]\]. The same fragmentation pathways were observed with compound **25** except that a different aglycone was present---in this case, tricin. It should be noted here that it was not possible to define the position of xylose substituent based only on the mass spectra, but we can presume that, due to steric hindrance, the most possible site for xylose group in compounds **24** and **25** is hydroxyl group at 4′ position.

In this work, we detected fine fragmentation spectra of precursors with relatively high molecular masses exceeding 1000 Da; i.e., compounds **34** and **35**, with masses of 1036 Da and 1052 Da, respectively. Analysis of the fragmentation pathways led to the conclusion that these compounds were tricin glycoconjugates that were acylated with dehydrodiferulic acids; to the best of our knowledge, these flavone derivatives are reported for the first time. We observed that the acylating group in compound **35** is cyclobutane diferulic acid \[[@B46-molecules-21-01229],[@B47-molecules-21-01229]\]. This ferulic acid dimer is formed by cyclodimerization in plant exposed to UV irradiation \[[@B48-molecules-21-01229]\]. Therefore, we cannot be certain if this compound is native to *Axyris amaranthoides* or if it was produced during sample preparation when the samples were subjected to UV rays from daylight irradiation. This compound has a characteristic fragmentation pattern in the positive ion mode. In the initial fragmentation step, one molecule of ferulic acid is detached from its dimer; consequently, an ion at *m*/*z* 859 is created that corresponds to a molecule containing ferulated diglucuronide (compound **19**). Further fragmentation steps are identical to those observed with compound **19**. In the negative ion mode, we observed a classic loss of aglycone, followed by the consecutive loss of two glucuronide moieties, resulting in the formation of an ion (*m*/*z* 371) that corresponds to a deprotonated cyclobutane dimer of ferulic acid. Finally, a fragment at *m*/*z* 193 is present corresponding to single, deprotonated molecule of ferulic acid.

Compound **34** contains non-cyclic dehydrodiferulic acid, which is frequently found in plant cell walls, especially in grasses, where it serves as a chemical link between chains of arabinoxylans, among others \[[@B47-molecules-21-01229],[@B49-molecules-21-01229]\]. Such dimers are produced by enzymatic reactions involving oxidative enzymes such as peroxidase; thus, it is likely that compound **34** is a native constituent of these plants. Dehydrodiferulates occur naturally in many isomeric forms \[[@B50-molecules-21-01229]\]; therefore, we cannot conclude which isoform is present in our finding. The fragmentation behavior of these components is not typical and is different from that observed for compound **35**. Here, in positive mode, we detected the loss of a 506 Da fragment corresponding to aglycone glucuronide (330 Da for tricin and 176 Da for glucuronic acid). Charge is retained on dehydrodiferuloyl glucoside (*m*/*z* 531), although the aglycone ion itself remains present, and this ion is the second most abundant ion in the spectrum. The fragmentation pathway obtained by analyzing the negative ion mode spectrum provides supplementary information regarding the identified compound. In the initial fragmentation step, we observed a typical loss of aglycone, followed by the loss of glucuronic acid; then, dehydrodiferulate is cleaved, followed by the loss of ferulic acid (176 Da). Consequently, a \[M − H\]^−^ ion with *m*/*z* 371 is observed, which corresponds to a glucose α-hydroxyferulate fragment. The proposed fragmentation scheme is presented in [Figure 5](#molecules-21-01229-f005){ref-type="fig"}.

3. Experimental Section {#sec3-molecules-21-01229}
=======================

3.1. General {#sec3dot1-molecules-21-01229}
------------

Thin-layer chromatography (TLC) was performed on cellulose plates (Merck, Darmstadt, Germany) using 1% KOH in MeOH for detection. The plates were irradiated with UV light at 366 nm before and after spraying.

Column chromatography was performed using Sephadex LH-20 (Pharmacia Biotech AB, Uppsala, Sweden) and cellulose powder Whatman CF 11 (Whatman International Ltd., Maidstone, Kent, UK). The solvent systems used were as follows: S1: (EtOAc--MeOH--H~2~O 100:6:6); S2: (EtOAc--MeOH--H~2~O 100:10:9.5); S3: (EtOAc--MeOH--H~2~O: 100:16:13) and S3: (EtOAc--MeOH--H~2~O: 100:18:15).

Solid-phase extraction (SPE) was performed using a System BAKER SPE 12-G) equipped with a Bond Elut C18 cartridge (Agilent Technologies, Palo Alto, CA, USA). Methanol, ethyl acetate and KOH were obtained from POCh, Gliwice, Poland. All reagents and solvents used for chromatography were of analytical or spectrometric grade.

3.2. Plant Materials {#sec3dot2-molecules-21-01229}
--------------------

*Axyris amaranthoides* herb was cultivated in the garden of the Department of Medical Plants at Poznan University of Medical Sciences. The seeds were obtained from Warsaw University Botanical Garden. The plant was collected in August 2012 during the flowering period and authenticated by MSc Katarzyna Guranowska from Warsaw University, Warszawa, Poland. Voucher specimens were deposited in the Department of Pharmacognosy, Poznan University of Medical Sciences, Poznan, Poland (AX 253).

3.3. Extraction of Phenolic Compounds {#sec3dot3-molecules-21-01229}
-------------------------------------

Air-dried *A. amaranthoides* herb (300 g) was successively extracted with MeOH and 50% MeOH. The combined extracts were evaporated to dryness, and the dry extract was treated with hot H~2~O, filtered and then partitioned between CHCl~3~ and EtOAc. The concentrated chloroform extract was loaded onto a Sephadex LH-20 column (Pharmacia Biotech AB, Uppsala, Sweden) and washed with 50% MeOH to yield a crude powder (10 mg). The ethyl acetate fraction was chromatographed on cellulose powder with S1 as the eluent to yield a crude product (12 mg), which was then purified by Sephadex LH-20 column chromatography and eluted with 50% MeOH. The aqueous residue after extraction with CHCl~3~ and EtOAc was separated on a cellulose column; fractions were eluted first with S2, then with S3 and finally, with S4, yielding 128 fractions. After TLC, control fractions 73--90 were combined and rechromatographed on Sephadex LH-20 using first H~2~O and then 50% MeOH to yield another product (30 mg). Final purification of the obtained products was achieved using solid-phase extraction (SPE) according to the Svedström method with minor modifications \[[@B51-molecules-21-01229]\]. The cartridge was first conditioned with 10 mL of methanol and 5 mL of water; then, 5 mL of water was added to the dry compounds, and 1 mL of this solution was loaded onto the cartridge. Fractions were then eluted with water followed by mixtures of H~2~O:MeOH of increasing concentration from 5% MeOH to 40% MeOH.

3.4. Liquid Chromatography with Mass Spectrometric Detection {#sec3dot4-molecules-21-01229}
------------------------------------------------------------

All fractions (see [Section 3.3](#sec3dot3-molecules-21-01229){ref-type="sec"}) were analyzed using an HPLC/MS system comprising a Waters Acquity UPLC system (Waters, Milford, MA, USA) combined with a Q-ToF mass spectrometer, model micrOTOF-q (Bruker Daltonics, Bremen, Germany). Analyses were carried out using Zorbax Eclipse XDB-C18 columns (2.1 mm × 150 mm, 3.5 µm and 2.1 mm × 100 mm, 1.8 µm; Agilent). Chromatographic separation using the Waters Acquity UPLC system was performed at a flow rate of 0.6 mL/min using mixtures of the following two solvents: A (99.5% H~2~O, 0.5% formic acid (*v*/*v*)); B (99.5% acetonitrile, 0.5% formic acid (*v*/*v*)). The column effluent was split 3:2 to allow 0.2 mL/min to be delivered to an ESI ion source. The elution steps were as follows: 0--8 min linear gradient from 5% to 30% B, 8--10 min linear gradient to 95% B, 10--12 min of isocratic flow at 95% B and a return to the initial condition after 3 min.

The micrOTOF-Q spectrometer consisted of ESI operating at ±4.5 kV, nebulization with nitrogen at 1.6 bar and a dry gas flow of 8.0 L/min at a temperature of 220 °C. For the pseudo MS3 analyses, additionally, in-source induced dissociation (ISCID) was set up at 80 eV to cleave *O*-glycosidic bonds in flavonoid conjugates enabling aglycone fragmentation spectra acquisition. The system was calibrated externally using a calibration mixture containing sodium formate clusters. Additional internal calibrations were performed for every run by injecting the calibration mixture using a divert valve during LC separation. All calculations were performed using the high precision calibration (HPC) quadratic algorithm. These calibrations yielded an accuracy of less than 10 ppm. MS/MS spectra were acquired at a frequency of one scan per second for ions that were chosen on the basis of preliminary MS experiments. The collision energy was dependent on the molecular masses of the compounds and was set between 10 and 25 eV. The instrument operated at a resolution higher than 10,000 (FWHM, full width at half maximum) using the program micrOTOF control version 2.3, and data were analyzed using the Data Analysis version 4 package, which was supplied by Bruker. Metabolite profiles were registered in positive and negative ion modes.

4. Conclusions {#sec4-molecules-21-01229}
==============

The use of an LC-MS/MS system comprising a rapid HPLC and a tandem MS/MS spectrometer equipped with a high-resolution time-of-flight analyzer permits the structural characterization of flavonoid glycoconjugates containing glucuronic acid and phenolic acyl substituents. However, due to the availability of complementary information resulting from differences in the fragmentation patterns for the positive and negative ions of these compounds, it is essential that analyses are performed using both modes of ionization. It is of particular importance that mechanisms observed for glycosides containing more than one molecule of glucuronic acid are dramatically different from those of flavonoid glycoconjugates containing sugars without carboxyl groups, especially when using the negative ion mode. Ions presented in [Figure 4](#molecules-21-01229-f004){ref-type="fig"} may serve as diagnostic ones for correct recognition of presented here specific groups of flavonoid diglucuronides. HRMS analyses performed in both positive and negative ion modes might permit the structural characterization of glucuronyloglucosides and di- or triglucuronides. Such a system allows also for unambiguous differentiation between isomeric and isobaric compounds in opposite to low resolution MS. Additionally, we showed that, in MS/MS mode, differentiation of isobaric fragments (ferulate and glucuronate, coumarate and rhamnose, etc.) is also of great importance and is possible only on high-resolution MS systems. The use of modern analytical equipment might enable the characterization of potential new molecules as presented in this study, in which we demonstrate the acylation of flavone glucuronides with dehydrodiferulic acids. However, one should keep in mind that mass spectrometry itself does not allow for unambiguous identification of compounds and proposed structures should always be additionally confirmed using other methods, such as NMR spectroscopy. In our case, unfortunately, it was not possible due to the fact that these compounds were present in samples in very low amounts.
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![Structures of flavonoid aglycones identified in *Axyris amaranthoides*.](molecules-21-01229-g001){#molecules-21-01229-f001}

![Extracted ion chromatogram at *m*/*z* 815 showing all isomeric and isobaric ions. Asterisks indicate isomeric compounds not possible to distinguish due to very similar spectra to compounds **3**, **4** or **27**.](molecules-21-01229-g002){#molecules-21-01229-f002}

![Mass spectra registered in positive and negative ion mode for isomeric and isobaric compounds: chrysoeriol 7-*O*-\[2-*O*-feruloyl-glucuronopyranosyl-(1-3)-*O*-glucopyranoside\] (**3**), luteolin 7-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\] (**4**) and isorhamnetin 3-*O*-\[2′-*O*-coumaroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\] (**27**).](molecules-21-01229-g003){#molecules-21-01229-f003}

![Structures of the characteristic product ions of flavonoid glucuronates, (**a**) *m*/*z* 495 found in acylated at middle sugar moiety compounds, with linear fragment comprising two units of glucuronic acid and one unit of glucose; and (**b**) *m*/*z* 511 corresponding to methylated diglucuronate acylated with *p*-coumaric acid. Ions were found in the collision induced dissociation fragmentation (CID MS/MS) spectra, registered in negative mode, referred to the compounds from [Table 1](#molecules-21-01229-t001){ref-type="table"} and spectra in [supplementary data](#app1-molecules-21-01229){ref-type="app"}.](molecules-21-01229-g004){#molecules-21-01229-f004}

![Proposed fragmentation pathway for compound 34 based on MS/MS spectrum registered in negative ion mode.](molecules-21-01229-g005){#molecules-21-01229-f005}

molecules-21-01229-t001_Table 1

###### 

Flavonoid glycosides tentatively identified in *Axyris amaranthoides*.

  \#   Name                                                                                                                        Elemental Composition   Exact Monoisotopic Mass (Da)   Fragment Ions in Positive Ion Mode (*m*/*z*)   Fragment Ions in Negative Ion Mode (*m*/*z*)
  ---- --------------------------------------------------------------------------------------------------------------------------- ----------------------- ------------------------------ ---------------------------------------------- ----------------------------------------------
  1    Isorhamnetin 3(*7*)-*O*-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside                                                    C~28~H~28~O~19~         668.1224                       669, 493, 317                                  667, 351, 315, 193, 175
  2    Chrysoeriol 7-*O*-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside                                                          C~28~H~28~O~18~         652.1275                       653, 477, 301                                  651, 351, 299, 175
  3    Chrysoeriol 7-*O*-\[2-*O*-feruloyl-glucuronopyranosyl-(1-3)-*O*-glucopyranoside\]                                           C~38~H~38~O~20~         814.1956                       815, 653, 477                                  813, 513
  4    Luteolin 7-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                         C~37~H~34~O~21~         814.1592                       815, 463,2 87                                  814, 527, 285, 193
  5    Tricin 7-*O*-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside                                                               C~29~H~30~O~19~         682.1381                       683, 507, 331                                  681, 351, 193, 175
  6    Tricin 7-*O*-\[2-*O*-feruloyl-glucopyranosyl-(1-3)-*O*-glucuronopyranoside\]                                                C~39~H~40~O~21~         844.2062                       845, 683, 507                                  843, 513
  7    Tricin 7-*O*-{2′-*O*-feruloyl-\[glucopyranosyl-(1-3′)-*O*-glucopyranosyl\]-(1-2)-*O*-glucuronopyranoside}                   C~45~H~50~O~26~         1006.259                       1007, 507                                      1005, 675, 513
  8    Isorhamnetin 3(*7*)-*O*-glucuronopyranoside                                                                                 C~22~H~20~O~13~         492.0904                       493, 317                                       491, 315
  9    Isorhamnetin 3(*7*)-*O*-{3′-*O*-coumaroyl-\[glucuronopyranosyl-(1-2′)-*O*-glucopyranosyl\]-(1-2)-*O*-glucuronopyranoside}   C~43~H~44~O~26~         976.212                        977, 815, 493, 317                             975, 811, 659, 513, 495, 337, 315
  10   Syringetin 3-*O*-\[2′-*O*-feuroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                        C~39~H~38~O~23~         874.1804                       875, 523, 347                                  873, 527, 333, 193
  11   Apigenin 7-*O*-{2′-*O*-feruloyl-\[glucopyranosyl-(1-3′)\]-*O*-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside}             C~43~H~44~O~25~         960.2171                       961, 799, 447, 271                             959, 689, 527, 193
  12   Isorhamnetin 3(*7*)-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                C~38~H~36~O~22~         844.1698                       845, 493, 317, 177                             843, 649, 527, 315, 193
  13   Chrysoeriol 7-*O*-{3′-*O*-feruloyl-\[glucuronopyranosyl-(1-2′)\]-*O*-glucopyranosyl-(1-2)-*O*-glucuronopyranoside}          C~44~H~46~O~26~         990.2277                       991, 829, 477, 301                             989, 689, 495
  14   Tricin 7-*O*-{3′-*O*-feruloyl-\[glucuronopyranosyl-(1-2)\]-*O*-glucopyranosyl-(1-2)-*O*-glucuronopyranoside}                C~45~H~48~O~27~         1020.238                       1021, 859, 507, 331                            1019, 689, 495
  15   Tricin 7-*O*-{3′-*O*-coumaroyl-\[glucuronopyranosyl-(1-2′)\]-*O*-glucopyranosyl-(1-2)-*O*-glucuronopyranoside}              C~44~H~46~O~26~         990.2277                       991, 829, 507, 331                             989, 659, 495
  16   Tricin 7-*O*-glucuronopyranoside                                                                                            C~23~H~22~O~13~         506.105                        507, 331                                       505, 490, 329, 314
  17   Tricin 7-*O*-\[2′-*O*-sinapoyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                           C~40~H~40~O~23~         888.196                        889, 507, 383, 331, 207                        887, 557, 399, 223
  18   Chrysoeriol 7-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                      C~38~H~36~O~21~         828.1749                       829, 477, 353, 301, 177                        827, 527, 333, 193
  19   Tricin 7-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                           C~39~H~38~O~22~         858.1854                       859, 507, 331                                  857, 527, 193
  20   Tricin 7-*O*-\[2′-*O*-coumaroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                          C~38~H~36~O~21~         828.1749                       829, 507, 331, 147                             827, 497, 333, 163
  21   Tricin 7-*O*-{3-*O*-feruloyl-\[glucopyranosyl-(1-2′)-*O*-glucuronopyranosyl\]-(1-2)-*O*-glucuronopyranoside}                C~45~H~48~O~27~         1020.238                       1021, 683, 507, 339, 177                       1019, 689, 495
  22   Tricin 5-*O*-glucuronopyranosyl-7-*O*-glucopyranoside                                                                       C~29~H~32~O~18~         668.1588                       669, 507, 331                                  667, 491, 329
  23   Tricin 7-*O*-\[2′-*O*-5-hydroxyferuloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                  C~39~H~38~O~23~         874.1803                       875, 507, 369, 331                             873, 543, 351, 209
  24   Chrysoeriol 4′-*O*-xylopyranosyl-7-*O*-\[2′-*O*-coumaroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                C~42~H~42~O~24~         930.2066                       931, 799, 609, 433, 301                        929, 797, 497, 163
  25   Tricin 4′-*O*-xylopyranosyl-7-*O*-\[2′-*O*-coumaroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                     C~43~H~44~O~25~         960.2171                       961, 829, 507, 463, 331                        959, 827, 497
  26   Tricin 7-*O*-\[glucuronopyranosyl-(1-2)-*O*-methyloglucuronopyranoside\]                                                    C~30~H~32~O~19~         696.1537                       697, 521, 331                                  695, 533, 329
  27   Isorhamnetin 3(7)-*O*-\[2′-*O*-coumaroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                 C~37~H~34~O~21~         814.1592                       815, 493, 317                                  813, 649, 497, 315, 163
  28   Chrysoeriol 7-O-glucuronopyranoside                                                                                         C~22~H~20~O~12~         476.0954                       477, 301                                       \-
  29   Apigenin 7-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                         C~37~H~34~O~20~         798.1643                       799, 447, 331, 271                             797, 603, 527, 333, 193
  30   Chrysoeriol 7-*O*-\[2′-*O*-coumaroyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                     C~37~H~34~O~20~         798.1643                       799, 477, 301                                  797, 497
  31   Tricin 7-*O*-\[2′-*O*-feruloyl-glucuronopyranosyl-(1-2)-*O*-methyloglucuronopyranoside\]                                    C~40~H~40~O~22~         872.2011                       873, 521, 331, 177                             871, 677, 519, 329
  32   Tricin 7-*O*-\[2′-*O*-benzoyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                            C~36~H~34~O~20~         786.1643                       787, 507, 331                                  785, 455, 333, 121
  33   Tricin 7-*O*-\[2′-*O*-coumaroyl-methyloglucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                   C~39~H~38~O~21~         842.1905                       843, 507, 331                                  841, 695, 633, 511, 329, 163
  34   Tricin 7-*O*-\[2′-*O*-dehydrodiferuloyl-glucopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                      C~49~H~48~O~25~         1036.2479                      1037, 531, 331                                 1035, 705, 547, 371
  35   Tricin 7-*O*-\[2′-*O*-dehydrodiferuloyl-glucuronopyranosyl-(1-2)-*O*-glucuronopyranoside\]                                  C~49~H~48~O~26~         1052.2428                      1053, 859, 507, 331                            1051, 721, 563, 387
